Our genome-wide CRISPR screens suggest that ‘Jak-STAT signaling pathway’ is highly associated with anti-PD1 responsiveness, and altered IFNγ signaling pathway has been implicated as a molecular mechanism underlying resistance to cancer immunotherapy [16]. The gene discussed is IFNG; the disease is cancer.